» Articles » PMID: 10233744

Direct Ni2+ Antigen Formation on Cultured Human Dendritic Cells

Overview
Journal Immunology
Date 1999 May 8
PMID 10233744
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The possible direct antigen formation of Ni2+ on antigen-presenting cells (APCs) was studied with cultured human dendritic cells (DCs) obtained from 10 subjects contact allergic to Ni2+ and six non-allergic control individuals. All contact allergic subjects showed a significantly increased peripheral blood mononuclear cell (PBMC) response in vitro to Ni2+. DCs were expanded from the plastic-adherent cell fraction of PBMCs by culturing with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) for 7 days to obtain immature DCs, and with the addition of monocyte-conditioned medium for another 4 days, for DC maturation. The DCs were pulsed for 20 min with Ni2+ (50 micrometers) in protein-free Hank's balanced salt solution (HBSS) and added to freshly prepared autologous responder PBMCs. With five allergic subjects, immature DCs pulsed with Ni2+ demonstrated a significant capacity to activate Ni2+-reactive lymphocytes. With the remaining five patients and the six controls no difference in lymphocyte proliferation was observed between Ni2+-pulsed and non-pulsed immature DCs. In contrast, with mature Ni2+-pulsed DCs from both 'positive responder' (n=4) and 'non-responder' (n=4) patients, there was a significantly stimulated PBMC proliferation, whereas with the controls (n=4) still no activation was observed. Our results indicate that direct formation of the antigenic determinant of Ni2+ on APCs is possible and that Ni2+ uptake and processing mechanisms may not play a major role. Differences in the ease of activation of Ni2+-reactive lymphocytes are discussed in terms of a possible heterogeneity in the availability of Ni2+-reactive groups presented on endogenous peptides bound in the antigen binding groove of human leucocyte antigen (HLA) class-II molecules.

Citing Articles

Nuclear factor erythroid 2 - related factor 2 and its relationship with cellular response in nickel exposure: a systems biology analysis.

Jimenez-Vidal L, Espitia-Perez P, Torres-Avila J, Ricardo-Caldera D, Salcedo-Arteaga S, Galeano-Paez C BMC Pharmacol Toxicol. 2019; 20(Suppl 1):78.

PMID: 31852525 PMC: 6921378. DOI: 10.1186/s40360-019-0360-4.


Nickel ions selectively inhibit lipopolysaccharide-induced interleukin-6 production by decreasing its mRNA stability.

Asakawa S, Kishimoto Y, Takano T, Okita K, Takakuwa S, Sato T PLoS One. 2015; 10(3):e0119428.

PMID: 25742007 PMC: 4351189. DOI: 10.1371/journal.pone.0119428.


[Tolerance induction towards nickel. From animal model to humans].

Artik S, Gleichmann E, Ruzicka T Hautarzt. 2004; 55(11):1052-9.

PMID: 15365644 DOI: 10.1007/s00105-004-0815-3.


Early inflammatory markers in elicitation of allergic contact dermatitis.

Martin A, Gallino N, Gagliardi J, Ortiz S, Ruiz Lascano A, Diller A BMC Dermatol. 2002; 2:9.

PMID: 12167174 PMC: 122084. DOI: 10.1186/1471-5945-2-9.

References
1.
Menne T, Holm N . Nickel allergy in a female twin population. Int J Dermatol. 1983; 22(1):22-8. DOI: 10.1111/j.1365-4362.1983.tb02108.x. View

2.
Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

3.
Kapsenberg M, Res P, Bos J, Schootemijer A, Teunissen M, van Schooten W . Nickel-specific T lymphocyte clones derived from allergic nickel-contact dermatitis lesions in man: heterogeneity based on requirement of dendritic antigen-presenting cell subsets. Eur J Immunol. 1987; 17(6):861-5. DOI: 10.1002/eji.1830170620. View

4.
Romagnoli P, Labhardt A, Sinigaglia F . Selective interaction of Ni with an MHC-bound peptide. EMBO J. 1991; 10(6):1303-6. PMC: 452787. DOI: 10.1002/j.1460-2075.1991.tb07648.x. View

5.
Silvennoinen-Kassinen S, Ikaheimo I, Karvonen J, Kauppinen M, Kallioinen M . Mononuclear cell subsets in the nickel-allergic reaction in vitro and in vivo. J Allergy Clin Immunol. 1992; 89(4):794-800. DOI: 10.1016/0091-6749(92)90433-3. View